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Results. It was determined that these cells are sensitive to radiation damage in a dose dependent manner and in an order of
magnitude that respects the theoretical prediction of biological efﬁcacy against both types of radiation employed.
Conclusion. This study establishes and characterizes the basics of a model of the original irradiation on a cell type not extensively
studied in terms of their response to radiation or clinical signiﬁcance in the toxicity and radiation repair: human mesenchymal
stemcells. Themodel developedanddescribed is the basis for increasing knowledgeof radiobiology of stemcells, and is applicable
to other cell types.
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Introduction. Ibandronate (IBD) is a bisphosphonate used in hypercalcaemia-related cancers, in complications from bone metas-
tasis and in postmenopausal osteoporosis and has often been associated with osteoradionecrosis, especially amongst cancer
patients receiving radiation to the head and neck area.
Objectives. To determine the cytotoxicity of IBD in combination with ionizing radiation (IR) treatment by evaluating its genotoxic
and cytotoxic effects in non-tumoral cells.
Methods. The genotoxic effect of IBD was studied by means of the micronucleus test in cytokinesis-blocked cells of human
lymphocytes irradiated to 2Gy irradiation, while the cytotoxic effect was studied by a cell viability test (MTT) in PNT2 cells before
and after exposure to different X-ray doses (0–20Gy). The results of these treatments were compared with those elicited by
recommended human dose of Zoledronic acid (Z5%).
Results. At the concentrations of IBD recommended for humans, we did not determine any genotoxic, cytotoxic or synergistic
effect with ionizing radiation. With higher concentrations we established a cytotoxic effect on PNT2 cells (p<0.001); the combined
treatment with IR had a more pronounced effect than individual treatments (p<0.001), increasing the enhancement ratio (1.3)
and sensitization factor (23.6%). With the concentration of Z(5%), the combined treatment had a more pronounced effect than
individual treatments(p<0.001). The effect was synergic (CI < 1), increasing the Z enhancement ratio (2.6) and sensitization factor
(56%). For the genotoxic effect, only the administration of Z after irradiation (IR+Z) increased chromosome damage (p<0.001)
and the sensitization factor (35.7%).
Conclusion. The recommended clinical concentrations of IBD did not induce cytotoxic or genotoxic damage in non-tumor cells
neither did it show an additive effect with the IR. Only at very high concentrations is an increase in cytotoxicity with signiﬁcant
radiosensitizing noted similar to that produced by Z5%.
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Purpose. To determine the potentially paradoxical effect of rosmarinic acid (RA), typically being radioprotective when applied to
non-tumour cells yet conversely displaying a sensitizing action when applied to metastatic (B16F10) melanoma cells.
Methods. To analyze the radioprotective effects of the substances studied on cell viability and survival, we used the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay for 24 or 48h in B16F10 (melanoma) cell lines when they
were administered before exposure to different X-ray doses (4, 6, 8, 10 and 0Gy). An analysis of variance (ANOVA) of repeated
means was used to compare the percentages of surviving cells. This was complemented by least signiﬁcant deference analyses
to contrast pairs and means. To determine the Protection Factor (PF) the formula described by Sarma and Kesavan (1993) was
modiﬁed for the analysis of growth inhibition.
Results. RA shows a signiﬁcant genoprotective capacity (p<0.001) against X-rays with a protection factor of 58%, and a dose
reduction factor of 7.2. Cell survival obtained with RA after exposure to 10Gy of X-rays showed a protection factor of 47.5%, thus
eliminating 29.1% of radiation-induced cell death in normal prostate epithelial cells (PNT2) (p<0.001). However, in the metastatic
B16F10 melanoma cells, RA acted not as a radioprotector but as a sensitizing agent, increasing cellular death by 42% (p<0.001)
and producing an enhancement ratio of 2.36.
